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Democratic Deliberation and the Ethical
Review of Human Subjects Research
Govind Persad

The Presidential Commission for the Study of Bioethical Issues (PCSBI)
recently introduced “[t]he principle of democratic deliberation” (2010;
2012) as part of its reports on the ethics of synthetic biology and of human subjects research. The PCSBI noted that democratic deliberation is
“a less familiar principle in bioethics than the principles of beneficence
and justice” (2010, 30); indeed no other prominent list of bioethical principles lists anything similar (Veatch 2007). Though new to lists of bioethical principles, democratic deliberation has been employed elsewhere in
practical ethics (Gutmann and Thompson 2004, 18–19, 31, 33).
This chapter explains democratic deliberation and considers its implications for ethical review of human subjects research. It argues that
democratic deliberation favors the inclusion of research participants’
perspectives in ethical review as well as the ethical review of “public benefits” research.
10.1 Democratic Deliberation Explained
Democratic deliberation involves a public exchange of ideas within and
across groups of ordinary citizens, experts, and political representatives.
Participants should aim to engage actively with one another, and to offer
reasons that are acceptable and intelligible to their interlocutors. Decisions should be revisable as new information and new perspectives come
into view (DHHS 2010).
The PCSBI emphasized the deliberative character of its own procedures, in particular when engaging with religious and moral concerns
about the synthetic biology innovations it was then evaluating (2010,
139). These examples of public involvement far exceed the current requirement in human subjects research that an Institutional Review Board
(IRB) include a nonscientific and a lay member (Fost and Levine 2007).
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Incorporating democratic deliberation into decision-making can render the resulting decisions both more respectful and more accurate. First,
by involving all parties in the decision-making process, democratic deliberation can ensure that the process’s outcomes, whatever they are, express participants’ values. Amy Gutmann, the PCSBI’s current chair, has
argued that even when some lose out in democrative deliberation, the
outcome is not imposed on them, but instead results from something they
authorized (Gutmann and Thompson 2004, 21–23). Such authorization
can differentiate a just from an unjust outcome, even when the content of
the two outcomes is identical.
Other legal and political contexts feature democratic deliberation. For
example, recent innovations in restorative justice emphasize deliberative
engagement between criminals and victims, which makes it possible for
both to see the legal resolution as just (Parkinson and Roche 2004, 510).
Within the civil law, deliberative engagement helps ensure that contentious processes—such as divorce proceedings and family disputes—respect both prevailing and defeated participants (Menkel-Meadow 2004,
361).
Deliberation can enhance accuracy as well as respectfulness. Each
participant in deliberation brings a distinctive positional perspective; an
ordinary citizen may have less technical knowledge than an expert but
more knowledge about how people are employing technology (Anderson
2003, 57). A well-structured deliberative body can, ideally, know more
than even its most knowledgeable individuals, rather than simply knowing as much as its average participant (Gutmann and Thompson 2004,
12).
10.2 Participatory Inclusion: Involving Research Participants in Ethical
Review
As we consider how to revise existing human subjects research regulations, consider that a revised Common Rule might incorporate democratic deliberation by drawing on the experience of research participants
themselves when reviewing human subjects research proposals. The
current regime charges IRBs with protecting research participants,
but assigns no member the task of representing research participants.
While IRBs must “[safeguard] the rights and welfare of human subjects” (45 CFR 44.107(a) (2011)), they are neither required to engage
deliberatively with research participants nor to provide a voice for participants in the ethical review process. The lay member on the IRB is
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not required to learn about, or advocate for, research participants’
concerns.
In contrast, professional ethics and policy review boards outside research ethics frequently represent the clients, governments, and professionals they regulate or protect (Porter 1987). These boards exemplify
the participatory inclusion of laypeople (Johnson 2009; Agarwal 2008).
Numerous legal provisions ensure the participatory inclusion of clients on
a variety of committees in the health care context, as shown in table 10.1.
10.2.1 Participatory Inclusion as Democratic Deliberation
How do participatory inclusion statutes advance democratic deliberation? Review boards that are not directly democratic (e.g., the National
Park Service’s board of directors) often are thought of as democratic
because a democratically elected official (the US president) appoints an
officer (the secretary of the interior) who in turn appoints the board.
In contrast, participatory inclusion aims at more direct legitimacy, by
mandating that the board reflect the perspectives of a variety of interests.
Does having a representative group member on an advisory board
suffice to drive that group toward democratic deliberation? I’ll consider
three potential objections: (1) that representing research participants on
boards doesn’t help protect them and can even hurt their interests, (2)
that research participants’ interests are best served by a notice-and-comment or survey process rather than a representative member on a board,
and (3) that democratic deliberation should have no special solicitude for
research participants.
Does Participatory Inclusion Protect Participants?
Rand Rosenblatt worries that a participant representative on an advisory
board might provide a veneer of approval without substantively influencing the board’s decisions (Rosenblatt 1978). Concerns that procedural
protections such as rights of voice and representation are inferior to
substantive protections have arisen elsewhere in criminal and civil law
(Cassell 2011; MacCoun 2005), and in the development of community
advisory boards for clinical research (NIAID 2009). This concern would
counsel against representing participants on boards and in favor of instead writing strong participant protections into research regulations.
Such a suggestion would parallel the more general argument that an advisory committee can deliberate effectively regardless of its composition,
and that considering a committee’s output is enough to assess its deliberative efficacy (Walters 2012, 681). But for deliberation to be effective,
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Cord blood stem cell banks

County boards of health

Mental illness advocacy

Developmental disability

Protection and advocacy service

Representatives of elderly,
needy, or underprivileged

Sufferers; family

Sufferers; parents and family

User advocates

Rehabilitation technology

Disabled and advocates (>50%)

Recipients; donors; public

Schools for the deaf

Deaf (>50%)

Physicians and pharmacists’
licensure

In-home supportive services

Current or former users
(>=50%)

Professional clients

RI

Electronic health information

Consumer member of state
board of health

Hearing aid fitters’ licensure

Health care associated infections

Consumers (2)

Mentally ill offender task force

Human subjects research

Consumers (2)

Hearing aid users

Health care appeals

Consumers

Mentally ill offenders; relatives

Federal

Adult day care

Clients (encouraged)

IN

Ind. Code 12-28-1-6(a)

La. Rev. Stat. Ann. 28-451.3(D)(2)

42 CFR 51.22(b)(2)

Federal
LA

Ga. Code Ann. 31-3-2(a)(6)

20 Ill. Comp. Stat. 2310/2310-577(d); Mich.
Comp. Laws. Ann. 333.2682(4)

S.D. Stat. Ann. 36-4-2.1, 36-11-4.1

Colo. Rev. Stat. Ann. 18.1-9.104(1)(c)(XIV)
(A-C)

R.I. Admin. Code 31-5-3.9.2

29 USCA 764 (D)(ii)

Ky. Rev. Stat. 167.037(2)

Cal. Welf. & Inst. Code 12301.3

Ia. Code. Ann. 135.156(2)(a)

Conn. Gen. Stat. Ann. 19a-490n(b)

N.H. Rev. Stat. Ann. 171-A:19-a(V)

Mass. Gen. Laws Ann. 6 166

Tenn. Code Ann. 71-2-410

42 USCA 907a(a)(2)(C)

Source

GA

IL; MI

SD

CO; AZ

KY

CA

IA

CT

NH

MA

TN

Federal

Social Security

Benefit recipients

Jurisdiction

Advisory board

Participants included

Table 10.1
160
Govind Persad

Downloaded from http://direct.mit.edu/books/book/chapter-pdf/223607/9780262320825_can.pdf by PENROSE LIBRARY- DU user on 03 March 2022

Democratic Deliberation, Ethical Review of Human Subjects Research

161

the deliberative body must “represent a personal, educational, and cultural variety of life experiences” (Estlund 1997, 191). Including research
participants in deliberation can help to advance this goal.
Despite his initial worries, Rosenblatt ultimately endorses involving
participants in the deliberative process, arguing that doing so can both
produce empowering outcomes and itself be empowering:
[I]t is important to remember that the value of consumer participation and agency
explanation does not lie solely in the opportunity to secure a different outcome.
What Professor Tribe has termed “the right to be heard from, and the right to be
told why . . . express the elementary idea that to be a person, rather than a thing,
is at least to be consulted about what is done with one.” Expressed in political
terms, this root concept of human dignity highlights the need for a reconstruction
of the democratic process, in which consultation over fundamental human needs
is not made meaningless by a labyrinthine bureaucracy. By offering unorganized
interests the right to participate in programs for their own benefit, the traditions
of structural due process also help to encourage its exercise and thereby help to
strengthen democratic capacity. (1978, 264)

In the Medicaid context, Rosenblatt therefore endorses “medical care
advisory committees,” which “include Medicaid recipients and other
consumers (as well as providers) in the policy-making process” by giving them “adequate opportunity for meaningful participation in policy
development and program administration” (1978, 264).
Survey Representation versus Personal Representation
Including participants’ perspectives might be achievable without including participants directly in ethical review: for instance, participants’ perspectives could be solicited via a notice-and-comment process analogous
to the requirement that administrative agencies solicit and respond to
public comments when they engage in rulemaking (Cuellar 2005, 421).
For instance, ethics review committees might be required to survey research participants and consider the results when deciding whether to
renew or approve protocols.
Representation via surveys, however, may fail to provide participants
sufficient voice. To see why, imagine that instead of adding new senators
when admitting a new state, new states were instead represented in the
Senate through surveys: whenever a bill is proposed in the Senate, new
states would be surveyed and the existing senators would be required to
attend to the survey results. The new states might complain that (1) senators will not be held accountable for attending to the survey results and
(2) minor decision-making will either require a surfeit of referenda or
exclusion of those represented by surveys. Similarly a survey of research
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participants might not be taken seriously by a review board and would be
unable to anticipate specific issues that arise in ethical review. In contrast,
a participant representative would be on equal footing with other board
members and well placed to investigate and deliberate about major and
minor issues as they arise. Finally, participatory inclusion approaches do
not rule out the use of surveys: the representative, for instance, could
survey other participants as part of her review process.
Why Represent Research Participants At All?
What is the normative argument for setting aside special seats for participants? After all, IRB-reviewed research is supported by tax revenue, and
benefits many individuals in society who do not participate in research,
yet there is no movement to represent these beneficiaries on IRBs.
That participatory inclusion requirements are widespread on boards
analogous to ethics review bodies, as table 10.1 indicates, already offers
intuitive support for the claim that setting aside seats for participants
is justified. But discussions of consociational democracy can provide an
additional, more theoretically developed basis for including participants
in the ethical review of research. Andreas Føllesdal describes a consociational system as follows:
[C]onsociational democracy . . . . is a non-territorial form of federalism, characterized by cooperation among elites of different segments of a society, often split
along religious or ethnic lines. It entails government by grand coalitions, granting
autonomy to groups with veto rights over matters important to them. (1998, 202)

Like consociationalism, participant representation constitutes “non-territorial federalism”: research participants should be represented in decisions
that affect them, even if we do not grant them “veto rights” as the consocialist might (Cuellar 2005, 417). Joshua Cohen and Joel Rogers have similarly
suggested that we open up more arenas in democracies for decision-making
by bodies of representatives of particular interest groups (1992).
10.2.2 Participatory Inclusion in the Human Subjects Research Context
Many participatory inclusion provisions include clients. Others include
people whom institutions evaluate or regulate. Participants are both objects of evaluation and clients: as such, participatory inclusion seems no
less appropriate in a research context than in either of the two it melds.
How might research participants’ perspectives be better integrated
into the ethics review process via participatory inclusion? Laurie Flynn
and Ronald Honberg suggest that IRBs reviewing mental health research
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should “require the inclusion of individuals who have personally experienced severe mental illnesses as consumers or family members,” because
“consumers and family members, by virtue of their personal experiences,
are more likely to focus on those aspects of research designs which may
impact (positively or negatively) on the well-being of vulnerable research
subjects” (1999, 188). Flynn and Honberg, however, mandate the inclusion of patients, rather than research subjects. Although research subjects
resemble patients, subjects and patients are importantly different: for instance, some subjects are healthy volunteers (Keane 2008, 352), and the
common good can justify risks to consenting subjects that could not be
justified for ordinary patients (Katz 1993, 17).
Additional regulations on IRB composition along the lines Flynn
and Honberg suggest, however, may exacerbate concerns that IRBs are
overbureaucratized (Fost and Levine 2007, 2196). Regulations on composition that prevent IRBs from achieving a quorum could produce “substitution effects,” such as pressures to strip jurisdiction from IRBs, that
vitiate their direct effects.
Concerns about overbureaucratization might counsel permitting and
encouraging, but not requiring, that research participants be represented
in ethical review. This parallels the approach ultimately taken in staffing
the boards of the PPACA’s health insurance “exchanges.” Public comment
suggested that board members should have various specific forms of expertise and background. DHHS responded by requiring that “at least one
member of the Exchange’s board must include one voting member who
is a consumer representative,” but stopped short of mandating more specific expertise (77 Fed. Reg. 18,301, 18,310).
Representation by advocates rather than fellow participants is also
possible, and might help alleviate overbureaucratization concerns by
widening the pool of potential representatives or allowing current nonscientific IRB members to serve as advocates. Some nonscientific or unaffiliated members required by current IRB regulations see their roles as
including “[r]epresenting . . . human subjects’ interests”; “[r]eviewing the
research from the point of view of a potential subject”; “[a]cting as the
ally or the peer of the research subject,” and “[a]cting as a patient advocate and surrogate subject” (Porter 1997, 2 tbl. 1). Nonvoting observers
or advisors who explicitly represent research participants’ perspectives
might augment the phenomenon Porter identifies: Sirotin et al. suggest
that “[p]rofessionals who work extensively with prospective research
populations could help articulate those perspectives and should be encouraged to formally explore those perspectives, perhaps through focus
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groups and interviews,” and that “IRBs might also work with research
subject advocates, who work closely with research participants and seek
to represent their perspectives” (2010, 15). Advocates might have expertise that makes them better able to protect participants’ interests, may
not be vulnerable to conflicts of interest, or might have broader expertise
in the conduct of research than individual participants might. These arguments could be counterbalanced, however, by symbolic and practical
advantages of having the representative come from the group being represented (Minow 1991, 278–79).
Those revising research ethics regulations should consider more explicitly including research participants’ perspectives in review (45 CFR
46.107(f)), which provides that the IRB may “invite individuals with
competence in special areas to assist in the review of issues which require
expertise beyond or in addition to that available on the IRB,” and may already allow the inclusion of participants. The current wording frames the
invitees as technical experts, which might seem to exclude participants.
But this provision might be understood, or even reworded, to recognize
the experiential expertise of research participants—a form of special
knowledge that they acquire through experiencing a medical condition
and participating in the research enterprise from the participant perspective (Bal, Bijker, and Hendriks 2004, 1340), just as it has been understood
to include expert bioethicists (DeRenzo and Wichman 1990, 6). While
the current provisions make these experts nonvoting members, the rules
could be revised to grant research participant members a voice as voters.
Meanwhile, although 45 CFR 46.111(b) directs the IRB to specially
scrutinize the substance of research on vulnerable subjects, it could also
justify modifying the review procedure, and thus present an avenue for
participant inclusion. Where research proposes to involve vulnerable
populations, protecting their interests may counsel democratically including them or their representatives in the deliberations leading up to
research approval. The numerous participatory inclusion requirements in
statutes regulating mental health, elder care, and disability issues outside
of research (reviewed in table 10.1) lend support to such an approach. Indeed IRBs reviewing research on prisoners already are required to include
a “prisoner or prisoner representative” under 45 CFR 46.304.
10.3 The Need for Ethical Review of Public Benefits Research
Democratic deliberation also has implications for the exemption of
public benefits research—experimental research on the efficacy of
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programs like Medicare and Medicaid—from IRB review under 45
CFR 46.101(b)(5). The ANPRM suggests expanding the exemption. But
deliberative democratic concerns counsel against such expansions.
Public benefit research has the potential to force beneficiaries of public programs like Medicaid—who are often socially and economically
vulnerable—into research whose intended aims may be contrary to
participants’ interests. In contrast, ethical review of public benefits research requires those attempting to revise public benefit programs to get
the consent of current beneficiaries, which requires that researchers explain the proposed changes and provide an account of why research is
justified.
10.3.1 The Public Benefit Exemption
The history of the public benefit exemption suggests that it was initially
understood as a procedural change, rather than an exemption from ethical review entirely. Amici curiae in two appellate cases, C.K. v. New Jersey
Dep’t of Health & Human Servs., 92 F.3d 171 (3d Cir. 1996), and Beno
v. Shalala, 30 F.3d 1057 (9th Cir. 1994), argued that the public benefits
research exemption displaced public benefits research review from IRB
oversight, but not from oversight altogether.
Initially, IRBs reviewed public benefits research just as they reviewed
other human subjects research, and this practice was upheld in Crane v.
Matthews, 417 F. Supp. 532 (ND Ga. 1976). Crane prompted the public
benefits exemption, which removed public benefits research from IRBs’
jurisdiction. However, the Ninth Circuit in Beno recognized that public
benefit research exempt from IRB review is still subject to “an examination of the proposed project’s potential danger to participants’ physical, mental and emotional well-being,” Beno, 30 F.3d at 1070. The Third
Circuit agreed, stating that “the ‘additional layer of review’ from which
DHHS exempted public benefits experiments was the regulatory requirement of IRB review, not the statutory requirement of review for danger”
(C.K., 92 F.3d at 190).
Some have argued for expanding the exemption beyond research on
the benefit levels of federal programs like Medicare and Medicaid, thus
exempting a wide swath of research on public benefits. Law professor
Elmer Abbo argues that quality-improvement research should be exempt
from ethical review (Abbo 2007, 579), as does a Hastings Center working group (Baily et al. 2006, S33). The Secretary’s Advisory Committee
on Human Research Protections (SACHRP) believes “institutions should
be able to apply the exemption to public programs supported by state
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agencies” as well as to federal programs (Office for Human Research
Protections 2008).
These arguments have been accompanied by some de facto expansion of the exemption. The DHHS secretary has exempted randomized
trials on the quality of care among Medicare beneficiaries (Peikes et al.
2009). Research on the allocation rules for transplantable organs (Egan
et al. 2006), and on HIV epidemiology in at-risk communities (Merion
et al. 2005), has also been exempted. Most strikingly, research on the
prevalence of preterm birth and infant death among participants in the
Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) was held exempt. This research involved looking through
and analyzing infant death certificates, matching the names on the death
certificates to the names of children whose mothers received WIC prenatally, and comparing the death rates of African-American infants and
white infants whose mothers were on WIC (Khanani et al. 2010). One
can certainly imagine the mothers—had they been asked—refusing permission to have the death certificates coded in this way and matched, as
they were, with factors like race and whether the mother smoked tobacco
during pregnancy.
10.3.2 Fair Benefits and Public Benefits
Some have already endorsed the ethical review of public benefits research, though without explicitly invoking concerns about democratic
deliberation (Harvard Law Review 1995; Rosenbaum 1992, 123–26).
Democratic deliberation, I will argue, further favors the ethical review of
public benefits research.
Existing advocates have focused on the threat that public benefits research poses to participants’ medical well-being—that is, the threat that
research harms participants. This concern seems to fit into the branch of
research ethics that addresses risk–benefit balancing. There is an additional concern, however, that Beno and the federal regulations also seem
to recognize: the danger that research will use subjects against their will
for the benefit of others. This fits more clearly into the branches of research ethics that address informed consent and respect for participants.
In particular, public benefits research potentially stands in tension with
the Belmont Report’s dictum that research “should not unduly involve
persons from groups unlikely to be among the beneficiaries of subsequent
applications of the research” (National Commission 1979, 10). This “fair
benefits” requirement is echoed in other statements of clinical research
ethics, such as CIOMS’s requirement that research be “responsive to the
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health needs and the priorities of the population or community in which
it is to be carried out” (2002). Public benefits research frequently involves
taking resources away from poor and disadvantaged beneficiaries to see
whether these beneficiaries are able to maintain a tolerable standard of
living after losing benefits. Therefore the fair benefits requirement may
limit public benefits research on economically disadvantaged subjects,
particularly when conducted for the benefit of more advantaged individuals who want to minimize the tax burden of supporting entitlement
programs rather than for the benefit of other disadvantaged individuals.
Jan Blustein demonstrates this ethical tension in discussing the ethics of
the National Job Corps Study, a program evaluation that would fall under the current public benefits exception (Blustein 2005, 824). The study
randomized some Job Corps applicants into a control group that did not
get to participate in Job Corps (a program that offers educational and
vocational training to young adults between 16 and 24 years of age). The
study was ostensibly justified on the basis that “random assignment was
necessary because it was the only way to provide Congress and the public
with credible evidence about the success of the program” (Burghardt et al.
1997). However, participants complained about being treated as guinea
pigs and about the study serving the interests of wealthier individuals, but
not their own interests (Blustein 2005, 834). As Blustein suggests:
Research is prima facie unjust if some groups disproportionately bear the burdens
and others reap the benefits. Yet over the past 30 years, evaluations have been
conducted almost exclusively on public programs that benefit low-income and
vulnerable populations. Middle-class benefits like Medicare, the home mortgage
deduction, and the college Work-Study programs have been largely untouched.
To the extent that participants in social program evaluations assume risk or miss
out on desired services, this disparity would seem to raise questions of justice.
(2005, 838)

In a context—that of federal and state entitlement programs—where
there is already a “democracy deficit” and where deliberative involvement with current recipients of entitlements is limited, expanding the
public benefits research exemption risks allowing research that fails to
adequately represent the interests of participants, and so violates the
principle of democratic deliberation.
10.4 Conclusion
How would incorporating a democratic deliberation principle change
the ethics of human subjects research? I have argued that it would
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recommend greater inclusion of participants in the review process, and
would counsel against exempting public benefits research from ethical
review. This would not give deliberation unlimited scope. Legal institutions, for instance, often are initially constructed through intensive deliberation but later governed by systems of rules that grow out of that
initial deliberation (Dryzek 2000, 14). Likewise deliberation might be
more important in initial review or the drafting of regulations than in
day-to-day enforcement.
Nonetheless, the principle of democratic deliberation supports efforts
to make the ethical review of research more publicly accessible. The PCSBI continued to embrace a principle of democratic deliberation in its
recent work on human subjects research ethics (2012). The proposals I
suggest give this principle content.
Note
I am grateful to Holly Lynch and to audiences at the Stanford Center for Law and
the Biosciences Journal Club and the Petrie–Flom Center at Harvard Law School
for their helpful suggestions.
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